Gerard Damien
21Patents
3h-index
14Co-inventors
52Inventor score
Filing activity: Feb 21, 2003 → Oct 21, 2009
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6696481B2 | Salt of perindopril and pharmaceutical compositions containing it | Human Necessities | 7 | Expired |
| US7250531B2 | Process for the synthesis and crystalline form of agomelatine | Emerging Cross-Sectional Technologies | 6 | Expired |
| US7544839B2 | Process for the synthesis and crystalline form agomelatine | Emerging Cross-Sectional Technologies | 5 | Active |
| US7498466B2 | Process for the synthesis and crystalline form of agomelatine | Human Necessities | 2 | Active |
| US7361650B2 | γ-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it | Electricity | 2 | Expired |
| US7384932B2 | δd-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it | Human Necessities | 2 | Active |
| US7459568B2 | Alpha crystalline form of strontium ranelate | Human Necessities | 2 | Active |
| US7361649B2 | β-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it | Human Necessities | 2 | Expired |
| US7358240B2 | δ-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it | Human Necessities | 1 | Active |
| US7361652B2 | βd-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it | Performing Operations; Transporting | 1 | Expired |
| US7879842B2 | Beta-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it | Human Necessities | 1 | Active |
| US7361651B2 | γd-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it | Human Necessities | 1 | Expired |
| US7867997B2 | δ-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it | Human Necessities | 1 | Active |
| US7176197B2 | Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid | Human Necessities | 1 | Expired |
| US7867994B2 | Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid | Human Necessities | 1 | Active |
| US7498465B2 | Process for the synthesis and crystalline form of agomelatine | Chemistry; Metallurgy | 0 | Active |
| US7867996B2 | γ-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it | Electricity | 0 | Active |
| US7745482B2 | Alpha crystalline form of strontium ranelate | Human Necessities | 0 | Active |
| US7879841B2 | Delta D-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it | Human Necessities | 0 | Active |
| US7872001B2 | Gamma d-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it | Human Necessities | 0 | Active |
| US7867995B2 | βd-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it | Performing Operations; Transporting | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.